Jasleen Kaur Brar, MD
Internal Medicine · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Clinica Sierra Vista · 180 clinicians in this group
Hospitals listed: Community Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brar’s office at (559) 457-5500 to ask if they take your plan before you enroll.
State licence records
1 licence
- Illinois 125069769Temporary Medical Permit · since 2017 · expires 2020-06-26Specialty on the licence: Internal MedicineExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Medicaid work
$311,048 in 2024
Medicaid paid $311,048 for 11,836 billed services this clinician did in 2024, up to 220 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,964 | $310,488 |
| Short return visit (20+ min) | 2,484 | $425 |
| Return visit (30+ min) | 867 | $116 |
| Short return visit | 447 | $18 |
| Screening for depression is documented as negative, a follow-up plan is not required | 3,665 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 459 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 181 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 416 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 443 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 430 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 147 | $0 |
| Hemoglobin A1C level | 192 | $0 |
| 2024 | 11,836 | 16 | 220 | $311,048 |
| 2023 | 2,164 | 12 | 184 | $60,788 |
| 2022 | 3,745 | 4 | 320 | $133,348 |
| 2021 | 10,022 | 8 | 317 | $387,515 |
| 2020 | 2,351 | 3 | 291 | $106,823 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 384 | $60,363 |
| Short return visit (20+ min) | 525 | $425 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 73 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 24 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 81 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 65 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 83 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 25 | $0 |
| Hemoglobin A1C level | 21 | $0 |
| Short return visit | 62 | $0 |
| Return visit (30+ min) | 98 | $0 |
| Screening for depression is documented as negative, a follow-up plan is not required | 723 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,215 | $133,348 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 25 | $0 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 17 | $0 |
| Short return visit | 2,488 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 3,472 | $383,192 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 44 | $2,832 |
| Short return visit | 6,069 | $874 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 330 | $608 |
| URINE PREGNANCY TEST | 51 | $8 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 16 | $0 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 12 | $0 |
| Injection, ketorolac tromethamine, per 15 mg | 28 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 978 | $106,502 |
| Short return visit | 1,312 | $321 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 61 | $0 |
Drugs they prescribed that Part D paid
$273,021
Pharmacies billed $273,021 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (19 of 1,825) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,487 generic and 315 brand-name prescriptions · $273,021 in drug cost · 44 antibiotic prescriptions to 34 people · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 40 | $49,607 | $1,240 |
| Januvia | 29 | $44,959 | $1,550 |
| Ozempic | 41 | $37,429 | $913 |
| Tradjenta | 13 | $14,226 | $1,094 |
| Atrovent Hfa | 13 | $6,336 | $487 |
See all 47 drugs
| Jardiance | 40 | $49,607 | $1,240 |
| Januvia | 29 | $44,959 | $1,550 |
| Ozempic | 41 | $37,429 | $913 |
| Tradjenta | 13 | $14,226 | $1,094 |
| Atrovent Hfa | 13 | $6,336 | $487 |
| Basaglar Kwikpen U-100 | 24 | $6,102 | $254 |
| Lantus Solostar | 17 | $1,295 | $76 |
| Albuterol Sulfate Hfa | 30 | $945 | $31 |
| Atorvastatin | 123 | $680 | $6 |
| Amitriptyline | 12 | $603 | $50 |
| Nano 2nd Gen Pen Needle | 11 | $579 | $53 |
| Tamsulosin | 28 | $534 | $19 |
| Ezetimibe | 18 | $499 | $28 |
| Gabapentin | 58 | $430 | $7 |
| Levothyroxine | 56 | $361 | $6 |
| Lisinopril | 67 | $335 | $5 |
| Amlodipine Besylate | 85 | $333 | $4 |
| Duloxetine | 19 | $319 | $17 |
| Metformin | 49 | $278 | $6 |
| Metoprolol | 31 | $242 | $8 |
| Hydroxyzine | 26 | $230 | $9 |
| Metformin Hcl Er | 17 | $223 | $13 |
| Omeprazole | 61 | $218 | $4 |
| Losartan | 43 | $202 | $5 |
| Lisinopril-Hydrochlorothiazide | 16 | $176 | $11 |
| Diclofenac | 18 | $156 | $9 |
| Pantoprazole | 20 | $147 | $7 |
| Tizanidine | 17 | $143 | $8 |
| Losartan-Hydrochlorothiazide | 25 | $141 | $6 |
| Pravastatin | 13 | $132 | $10 |
| Glipizide Er | 16 | $123 | $8 |
| Levetiracetam | 12 | $104 | $9 |
| Montelukast | 18 | $98 | $5 |
| Escitalopram | 15 | $89 | $6 |
| Donepezil | 12 | $80 | $7 |
| Furosemide | 33 | $77 | $2 |
| Hydrochlorothiazide | 34 | $71 | $2 |
| Carvedilol | 29 | $69 | $2 |
| Tramadol | 15 | $65 | $4 |
| Clopidogrel | 15 | $62 | $4 |
| Simvastatin | 12 | $60 | $5 |
| Cyclobenzaprine | 36 | $58 | $2 |
| Ibuprofen | 11 | $52 | $5 |
| Famotidine | 13 | $47 | $4 |
| Fluconazole | 12 | $40 | $3 |
| Prednisone | 13 | $34 | $3 |
| Metoprolol | 14 | $30 | $2 |
Year by year
| 2024 | 1,825 | 190 | 1% (19) | 17% | $273,021 |
| 2023 | 142 | 53 | 0% (0) | None | $19,556 |
| 2022 | 863 | 195 | 2% (15) | 12% | $73,382 |
| 2021 | 1,292 | 301 | 2% (25) | 13% | $96,333 |
| 2020 | 112 | 67 | None | None | $9,244 |
| 2019 | 44 | 11 | None | None | $3,088 |
| 2018 | 34 | 12 | 0% (0) | None | $3,266 |
| 2017 | 12 | None | None | None | $1,602 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Atorvastatin | 12 | $239 | $20 |
2022: 22 drugs
| Tradjenta | 11 | $11,229 | $1,021 |
| Gabapentin | 43 | $1,312 | $31 |
| Atorvastatin | 58 | $769 | $13 |
| Metformin | 49 | $525 | $11 |
| Albuterol Sulfate Hfa | 12 | $499 | $42 |
| Levothyroxine | 20 | $447 | $22 |
| Amlodipine Besylate | 36 | $319 | $9 |
| Diclofenac | 11 | $317 | $29 |
| Metoprolol | 14 | $269 | $19 |
| Lisinopril | 31 | $221 | $7 |
| Carvedilol | 18 | $198 | $11 |
| Omeprazole | 15 | $172 | $11 |
| Pioglitazone | 11 | $165 | $15 |
| Losartan | 14 | $155 | $11 |
| Ibuprofen | 28 | $138 | $5 |
| Naproxen | 12 | $111 | $9 |
| Meloxicam | 13 | $107 | $8 |
| Glipizide Er | 11 | $106 | $10 |
| Oxybutynin Chloride | 12 | $96 | $8 |
| Azithromycin | 16 | $93 | $6 |
| Hydrochlorothiazide | 13 | $40 | $3 |
| Prednisone | 13 | $26 | $2 |
2021: 37 drugs
| Lantus Solostar | 22 | $9,495 | $432 |
| Albuterol Sulfate Hfa | 30 | $1,624 | $54 |
| Atorvastatin | 64 | $1,069 | $17 |
| Metoprolol | 37 | $897 | $24 |
| Droplet Pen Needle | 17 | $603 | $35 |
| Levothyroxine | 21 | $472 | $22 |
| Diclofenac | 22 | $466 | $21 |
| Losartan-Hydrochlorothiazide | 17 | $431 | $25 |
| Ibuprofen | 57 | $429 | $8 |
| Gabapentin | 30 | $413 | $14 |
| Lisinopril | 49 | $396 | $8 |
| Omeprazole | 24 | $390 | $16 |
| Amlodipine Besylate | 49 | $249 | $5 |
| Nitrofurantoin Mono-Macro | 12 | $242 | $20 |
| Metformin | 45 | $225 | $5 |
| Montelukast | 13 | $211 | $16 |
| Azithromycin | 23 | $176 | $8 |
| Losartan | 16 | $169 | $11 |
| Pioglitazone | 11 | $143 | $13 |
| Hydroxyzine | 20 | $143 | $7 |
| Glipizide Er | 12 | $139 | $12 |
| Mupirocin | 13 | $139 | $11 |
| Metoprolol | 23 | $131 | $6 |
| Paroxetine | 14 | $113 | $8 |
| Cyclobenzaprine | 13 | $113 | $9 |
| Amoxicillin-Clavulanate Potass | 14 | $100 | $7 |
| Euthyrox | 11 | $99 | $9 |
| Ciprofloxacin | 15 | $93 | $6 |
| Pantoprazole | 11 | $84 | $8 |
| Prednisone | 33 | $78 | $2 |
| Famotidine | 23 | $73 | $3 |
| Furosemide | 17 | $71 | $4 |
| Naproxen | 12 | $66 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $66 | $5 |
| Meloxicam | 16 | $47 | $3 |
| Hydrochlorothiazide | 16 | $36 | $2 |
| Tramadol | 11 | $17 | $2 |
2020: 1 drug
| Azithromycin | 12 | $117 | $10 |
Money from drug and device companies
$397 in 2025
| 2025 | 9 | 20 | None | $397 |
| 2023 | 1 | 1 | None | $19 |
| 2022 | 1 | 1 | None | $16 |
| 2019 | 2 | 2 | None | $35 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $78 | 3 payments
|
| Novo Nordisk | Ozempic | $70 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $69 | 3 payments
|
| Lilly USA | Mounjaro | $63 | 3 payments
|
| Cranial Technologies | Doc Band | $51 | 3 payments
|
| GlaxoSmithKline | Shingrix | $21 | 1 payment
|
See all 20 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-09 | Airsupra | $14 |
| Exact Sciences | Meals · 2025-11-04 | The Cologuard Plus Collection Kit | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-10-29 | Dupixent | $21 |
| Lilly USA | Meals · 2025-10-07 | Mounjaro | $30 |
| Cranial Technologies | Meals · 2025-09-17 | Doc Band | $18 |
| Sumitomo Pharma America | Meals · 2025-09-16 | Myfembree | $19 |
| Novo Nordisk | Meals · 2025-08-26 | Ozempic | $14 |
| Exact Sciences | Meals · 2025-08-01 | Cologuard Collection Kit | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-07-28 | Dupixent | $19 |
| Lilly USA | Meals · 2025-07-14 | Mounjaro | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-06-25 | Dupixent | $29 |
| Cranial Technologies | Meals · 2025-05-15 | Doc Band | $18 |
| Novo Nordisk | Meals · 2025-04-30 | Ozempic | $16 |
| Novo Nordisk | Meals · 2025-04-29 | Wegovy | $25 |
| Lilly USA | Meals · 2025-04-09 | Mounjaro | $19 |
| Mannkind | Meals · 2025-04-08 | Afrezza | $14 |
| Cranial Technologies | Meals · 2025-03-19 | Doc Band | $15 |
| Novo Nordisk | Meals · 2025-03-03 | None | $15 |
| GlaxoSmithKline | Meals · 2025-01-28 | Shingrix | $21 |
| Exact Sciences | Meals · 2025-01-28 | Cologuard Collection Kit | $27 |
See earlier years (2023, 2022, 2019)
2023: $19
| GlaxoSmithKline | Bexsero | $19 | 1 payment
|
2022: $16
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $16 | 1 payment
|
2019: $35
| Amgen | None | $19 | 1 payment
|
| Pfizer | Chantix | $16 | 1 payment
|
Professional record
- NPI
- 1932622206
- Licence
- IL 125069769Illinois 125069769: Expired
- Group
- Clinica Sierra Vista
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- Po Box 21810, Bakersfield, CA, 93390
- NPI first listed
- 2017-07-19
- NPI last updated
- 2026-04-07
- NPI record certified
- 2026-04-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4646 N. Marine Dr., Chicago, IL, 60640 · 517 S Madera Ave, Kerman, CA, 93630